newsfilter
← Latest News
ACCESS Newswire·

Xenetic Biosciences, Inc. Announces Pricing of $4.5 Million Underwritten Offering of Common Stock

FRAMINGHAM, MA / ACCESS Newswire / October 10, 2025 / Xenetic Biosciences, Inc. , a biopharmaceutical company focused on advancing innovative immuno-oncology